Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Liz Caldon

University of New South Wales

Australia

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Australia Professors in Cell Biology Cell Biology professors in Australia

Articles (9)

Year:

2026

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Collaborators (8)

Geraldine Laven-Law

Flinders University

AUSTRALIA

View details

Michelle Wykes

QIMR Berghofer Medical Research Institute

AUSTRALIA

View details

Emily Wong

Head of Regulatory Systems

Victor Chang Cardiac Research Institute

AUSTRALIA

View details

Quan Nguyen

Group Leader - Head of Genomics Machine Learning Lab

QIMR Berghofer Medical Research Institute

AUSTRALIA

View details

Joanna Achinger-Kawecka

Senior Lecturer

University of South Australia

AUSTRALIA

View details

Rebekah Ziegman

QIMR Berghofer Medical Research Institute

AUSTRALIA

View details

Joseph Rosenbluh

Lab Head

MONASH UNIVERSITY

AUSTRALIA

View details

Carla Alves

University of Southern Denmark

DENMARK

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Liz Caldon

Research Interests

Make your next move.

Explore related searches

Articles (9)

BRRIAR lncRNA alters breast cancer risk by modulating interferon signaling in cis and in trans

JNK pathway suppression mediates insensitivity to combination endocrine therapy and CDK4/6 inhibition in ER+ breast cancer

Unmatched Cell Line Collections Are Not Optimal for Identification of PARP Inhibitor Response and Drug Synergies

The potential of epigenetic therapy to target the 3D epigenome in endocrine-resistant breast cancer

SAM-DNMT3A, a strategy for induction of genome-wide DNA methylation, identifies DNA methylation as a vulnerability in ER-positive breast cancers

DNA repair biomarkers to guide usage of combined PARP inhibitors and chemotherapy: A meta-analysis and systematic review

miR-99b-5p, miR-380-3p, and miR-485-3p are novel chemosensitizing miRNAs in high-risk neuroblastoma (vol 30, pg 1119, 2022)

CDK4/6 inhibitor resistance in estrogen receptor positive breast cancer, a 2023 perspective

Selective Androgen Receptor Modulators in combination with CDK4/6 inhibitors demonstrate anti-cancer activity in preclinical treatment resistant ER plus AR plus breast cancer models

Collaborators (8)

Geraldine Laven-Law

Michelle Wykes

Emily Wong

Quan Nguyen

Joanna Achinger-Kawecka

Rebekah Ziegman

Joseph Rosenbluh

Carla Alves

Make your next move.